The US Food and Drug Administration said on Thursday that Global Pharma Healthcare is recalling its Artificial Tears Lubricant Eye Drops owing to suspected contamination. The eye drops were sold by EzriCare and Delsam Pharma.
Multidose vials of the drops were offered online in the United States. Those who have used them should cease and contact the FDA about any negative effects.
There have been 55 complaints of illnesses, including one death, in 12 different states that may be related to the items, and the CDC is now investigating.
The Centers for Disease Control and Prevention (CDC) claims it has received reports of corneal, intraocular fluid, respiratory, urinary tract, and systemic sepsis infections. One person died, while many others were hospitalized or suffered lifelong visual loss.
According to the agency’s findings, EzriCare’s artificial tears were the most often reported brand among the more than 10 used by persons with illnesses. You shouldn’t worry about any germs growing in these eye drops since they don’t include any preservatives.
Pseudomonas aeruginosa, germs resistant to several antibiotics, were found in opened EzriCare bottles. The CDC speculates that the germs were introduced either during usage or during production. Not yet opened bottles are being tested.
Located in New Jersey After learning of the investigation on January 20, EzriCare claimed in a statement that it promptly took measures to halt the distribution and sale of EzriCare Artificial Tears. We have been trying to reach as many people as possible to warn them against using the product.
Pseudomonas bacteria are widespread in the natural world and may be found in a variety of habitats. The CDC reports that Pseudomonas aeruginosa is often disseminated in hospitals and is becoming more difficult to treat due to drug resistance. More than 32,000 hospitalized patients in the United States contracted it in 2017, leading to roughly 2,700 fatalities.
